ATE357442T1 - Verfahren zur herstellung von candesartan cilexetil - Google Patents

Verfahren zur herstellung von candesartan cilexetil

Info

Publication number
ATE357442T1
ATE357442T1 AT04795674T AT04795674T ATE357442T1 AT E357442 T1 ATE357442 T1 AT E357442T1 AT 04795674 T AT04795674 T AT 04795674T AT 04795674 T AT04795674 T AT 04795674T AT E357442 T1 ATE357442 T1 AT E357442T1
Authority
AT
Austria
Prior art keywords
candesartan cilexetil
cilexetil
reaction
producing
producing candesartan
Prior art date
Application number
AT04795674T
Other languages
English (en)
Inventor
Marina Yu Etinger
Boris Fedotev
Ben-Zion Dolitzky
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34468494&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE357442(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of ATE357442T1 publication Critical patent/ATE357442T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04795674T 2003-10-16 2004-10-18 Verfahren zur herstellung von candesartan cilexetil ATE357442T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US51256603P 2003-10-16 2003-10-16
US52352403P 2003-11-18 2003-11-18
US53799504P 2004-01-21 2004-01-21
US56864904P 2004-05-05 2004-05-05

Publications (1)

Publication Number Publication Date
ATE357442T1 true ATE357442T1 (de) 2007-04-15

Family

ID=34468494

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04795674T ATE357442T1 (de) 2003-10-16 2004-10-18 Verfahren zur herstellung von candesartan cilexetil

Country Status (9)

Country Link
US (2) US7098342B2 (de)
EP (1) EP1685126B1 (de)
AT (1) ATE357442T1 (de)
CA (1) CA2542499A1 (de)
DE (1) DE602004005488T2 (de)
ES (1) ES2284068T3 (de)
IL (1) IL174868A0 (de)
PT (1) PT1685126E (de)
WO (1) WO2005037821A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7692023B2 (en) * 2004-02-11 2010-04-06 Teva Pharmaceutical Industries Ltd. Candesartan cilexetil polymorphs
CN101103021A (zh) * 2005-01-14 2008-01-09 特瓦制药工业有限公司 粗坎地沙坦西酯的制备
CN100400536C (zh) * 2005-04-30 2008-07-09 重庆圣华曦药业有限公司 坎地沙坦酯c-型晶体的制备方法
AR053517A1 (es) * 2005-06-06 2007-05-09 Medichem Sa Proceso para la preparacion de compuestos de tetrazolilo, uso de los mismos en el tratamiento de enfermedades circulatorias y formulaciones farmaceuticas que los contienen.
SI22127A (sl) * 2005-10-07 2007-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo kandesartan cileksetila
CZ302240B6 (cs) * 2006-03-16 2011-01-05 Zentiva, A. S Zpusob odstranování trifenylmethanové chránicí skupiny u prekursoru antihypertensiv majících labilní, metabolicky odbouratelnou skupinu
WO2008012371A1 (en) * 2006-07-28 2008-01-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of amorphous and crystalline forms of candesartan cilexetil using column chromatography
KR100995755B1 (ko) 2008-10-31 2010-11-19 일동제약주식회사 트리틸 칸데사르탄 실렉세틸의 개선된 제조방법
WO2011080684A1 (en) 2009-12-31 2011-07-07 Ranbaxy Laboratories Limited Process for the preparation of candesartan cilexetil
WO2011092666A1 (en) 2010-01-29 2011-08-04 Ranbaxy Laboratories Limited An improved process for the preparation of candesartan cilexetil, polymorphic forms of n-trityl candesartan and their uses thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151273A (en) * 1974-10-31 1979-04-24 The Regents Of The University Of California Increasing the absorption rate of insoluble drugs
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
IL95975A (en) 1989-10-24 1997-06-10 Takeda Chemical Industries Ltd N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5703110A (en) * 1990-04-27 1997-12-30 Takeda Chemical Industries, Ltd. Benzimidazole derivatives, their production and use
US6004989A (en) * 1990-04-27 1999-12-21 Takeda Chemical Industries, Ltd. Benzimidazole derivatives, their production and use
DE4023369A1 (de) 1990-07-23 1992-01-30 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
RU1836357C (ru) * 1990-07-23 1993-08-23 Др.Карл Томэ ГмбХ Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
US5210206A (en) * 1990-09-10 1993-05-11 Abbott Laboratories 1,3-oxazolyl substituted biphenyl
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
TW284688B (de) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
EP0550313A1 (de) * 1991-12-30 1993-07-07 Synthelabo 2-(Tetranol-5-yl)-(1,1'-Biphenyl)derivate, ihre Herstellung und Anwendung als Zwischenverbindungen
ES2092332T3 (es) * 1992-10-14 1996-11-16 Unilever Nv Aliño para ensalada.
US5281604A (en) * 1993-04-23 1994-01-25 American Cyanamid Company Angiotensin II receptor blocking 2,3,6-substituted quinazolinones
US5721263A (en) * 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases
US5298517A (en) * 1993-10-07 1994-03-29 American Cyanamid Company Angiotensin II receptor blocking agents
EP0668272B1 (de) * 1994-01-28 2000-07-12 Takeda Chemical Industries, Ltd. Ein Verfahren zur Herstellung von Tetrazolyl-Verbindungen
US6177587B1 (en) 1997-05-26 2001-01-23 Takeda Chemical Industries, Ltd. Production method of aminobenzene compound
SE9901667D0 (sv) * 1999-05-07 1999-05-07 Astra Ab Method and device for forming particles
WO2003014112A1 (fr) 2001-08-03 2003-02-20 Takeda Chemical Industries, Ltd. Cristal et procede de fabrication correspondant
KR20070118224A (ko) * 2005-01-06 2007-12-14 엘란 파마 인터내셔널 리미티드 나노입자형 칸데사르탄 제제

Also Published As

Publication number Publication date
US7098342B2 (en) 2006-08-29
WO2005037821A2 (en) 2005-04-28
US20050131037A1 (en) 2005-06-16
DE602004005488D1 (de) 2007-05-03
PT1685126E (pt) 2007-04-30
CA2542499A1 (en) 2005-04-28
US20060252939A1 (en) 2006-11-09
ES2284068T3 (es) 2007-11-01
DE602004005488T2 (de) 2007-11-29
EP1685126B1 (de) 2007-03-21
IL174868A0 (en) 2006-08-20
EP1685126A2 (de) 2006-08-02
WO2005037821A3 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
IL174868A0 (en) Preparation of candesartan cilexetil
DE602005011308D1 (de) Substituierte organopolysiloxane und ihre verwendung
TW200602387A (en) A polymer and a process for producing the same
ATE419916T1 (de) Verfahren zur herstellung von polymeren
UA83910C2 (ru) Способ получения 5-гидрокси-4-тиометилпиразольного соединения
ATE517094T1 (de) Verfahren zur herstellung von medetomidin und seinen salzen
TW200720238A (en) Intramolecular prins reaction and catalysts suitable therefor (citronellall to isopulegol)
ATE525341T1 (de) Verfahren zur herstellung von 1-acetyl-1- chlorcyclopropan
ATE398121T1 (de) Neue synthese von irbesartan
ATE449751T1 (de) Synthese von 6-aryl-6-alkyl-fulvenen, 6-aryl-6- alkenyl-fulvene und zugehörige verbindungen
ATE469873T1 (de) Verfahren zur umwandlung von ethylen in propylen
ATE554063T1 (de) Verfahren zur herstellung von ketonen aus alpha- oxocarboxylaten und arylbromiden
ATE384069T1 (de) Alkyliden-tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
DE602006005349D1 (de) Verfahren zur herstellung von hydrazon-derivaten
DE112008003640A5 (de) Verfahren zur Herstellung von 3,6-Dihydro-1,3,5-Triazin-Derivaten
DE602004014290D1 (de) Verfahren zur herstellung von 2,3,5-trimethylhydrochinondiacylaten
DE502004003819D1 (de) Gasgenerator
ATE421432T1 (de) Trägermaterial sowie verfahren zur herstellung eines wertdokumentes
RS20050933A (en) Process for the preparation of nonpeptide substit uted spirobenzoazepine derivatives
EA200701433A1 (ru) Получение ирбесартана
ATE522579T1 (de) Kondensationsvernetzende silikonschäume
DE602007009367D1 (de) Yl)-n-methylbenzylamin
DE60129696D1 (de) Verfahren zur regenerierung von festen sauren katalysatoren
BRPI0820269A2 (pt) Método de converter cataliticamente 2,2-dicloro-hexafluoro propano (hfc-216aa) em 2-cloro-1,1,1,2,3,3,3-heptafluoropropano (hfc-217ba).
ATE514675T1 (de) Ortho-substituierte pentafluorsulfanyl-benzole, verfahren zu ihrer herstellung sowie ihre verwendung als synthese-zwischenstufen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties